Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
39.04 USD | -2.25% | -2.30% | -1.66% |
Financials (USD)
Sales 2024 * | 2.71M | Sales 2025 * | 2.66M | Capitalization | 2.63B |
---|---|---|---|---|---|
Net income 2024 * | -153M | Net income 2025 * | -196M | EV / Sales 2024 * | 970 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 991 x |
P/E ratio 2024 * |
-17.3
x | P/E ratio 2025 * |
-13.9
x | Employees | 160 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.66% |
Latest transcript on Celldex Therapeutics, Inc.
1 day | -0.62% | ||
1 week | -2.78% | ||
Current month | +6.68% | ||
1 month | +3.42% | ||
3 months | +4.37% | ||
6 months | +43.65% | ||
Current year | +0.66% |
Managers | Title | Age | Since |
---|---|---|---|
Tibor Keler
FOU | Founder | 65 | 82-12-31 |
Anthony Marucci
FOU | Founder | 62 | 82-12-31 |
Sam Martin
DFI | Director of Finance/CFO | 53 | 09-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Herbert Conrad
BRD | Director/Board Member | 91 | 08-02-29 |
Cheryl L. Cohen
BRD | Director/Board Member | 58 | 22-06-15 |
Harry Penner
BRD | Director/Board Member | 78 | 96-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 2 M€ | -.--% | ||
0.06% | 1,487 M€ | +9.08% | - | |
0.02% | 9 M€ | +10.70% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 39 | -2.35% | 169 947 |
24-05-16 | 39.94 | -0.57% | 950,952 |
24-05-15 | 40.17 | +1.77% | 472,678 |
24-05-14 | 39.47 | -1.60% | 635,680 |
24-05-13 | 40.11 | +0.48% | 372,718 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.66% | 2.63B | |
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+48.49% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- CLDX Stock